<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Cancer Imaging</journal-id><journal-id journal-id-type="iso-abbrev">Cancer Imaging</journal-id><journal-title-group><journal-title>Cancer Imaging</journal-title></journal-title-group><issn pub-type="ppub">1740-5025</issn><issn pub-type="epub">1470-7330</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmc">4448630</article-id><article-id pub-id-type="publisher-id">3</article-id><article-id pub-id-type="doi">10.1102/1470-7330.2001.008</article-id><article-categories><subj-group subj-group-type="heading"><subject>Multidisciplinary Symposium &#x02014; Screening for Cancer: Monday 15 October 2001, 10.20&#x02013;12.45</subject></subj-group></article-categories><title-group><article-title>Colon cancer screening</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Heiken</surname><given-names>Jay P.</given-names></name><xref ref-type="aff" rid="Aff1"/></contrib><aff id="Aff1">Mallinckrodt Institute of Radiology, Washington University School of Medicine, St Louis, Missouri USA </aff></contrib-group><pub-date pub-type="epub"><day>5</day><month>5</month><year>2015</year></pub-date><pub-date pub-type="pmc-release"><day>5</day><month>5</month><year>2015</year></pub-date><pub-date pub-type="ppub"><year>2001</year></pub-date><volume>2</volume><issue>1</issue><fpage>10</fpage><lpage>14</lpage><permissions><copyright-statement>&#x000a9; International Cancer Imaging Society 2001</copyright-statement></permissions><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; International Cancer Imaging Society 2001</meta-value></custom-meta></custom-meta-group></article-meta></front><body><p>Colorectal cancer is a major health problem worldwide. Last year in the United States alone, more than 130 000 people were diagnosed with colorectal cancer and more than 56 000 died of their disease[<xref ref-type="bibr" rid="CR1">1</xref>]. Fortunately, this neoplasm is highly suited to screening because of its long preclinical phase, during which it is detectable and curable[<xref ref-type="bibr" rid="CR2">2</xref>]. Nevertheless, screening programs for colorectal cancer have been only partly successful, owing largely to poor patient compliance with screening recommendations[<xref ref-type="bibr" rid="CR3">3</xref>,<xref ref-type="bibr" rid="CR4">4</xref>]. A number of organizations including the World Health Organization (WHO), the American Cancer Society (ACS), the Agency for Health Care Policy and Research (AHCPR), the US Preventive Service Task Force (USPSTF), and the American Gastroenterology Association (AGA) have issued or endorsed guidelines for colorectal cancer screening. This review summarizes the clinical evidence supporting colorectal cancer screening in the average-risk population and in high-risk groups, discusses the advantages and disadvantages of the available screening tests, and outlines the currently recommended guidelines for screening based on risk category.</p><sec id="Sec1"><title>Average-risk population</title><p>Average-risk patients are asymptomatic individuals aged 50 years of age or older who have no personal or family history of colorectal cancer or adenomatous polyps and no history of inflammatory bowel disease. The two most recently published screening recommendations, those of the ACS[<xref ref-type="bibr" rid="CR5">5</xref>] and AHCPR[<xref ref-type="bibr" rid="CR6">6</xref>], present guidelines for screening average-risk patients in the form of lists of options (Table <xref rid="Tab1" ref-type="table">1</xref>). The options include annual fecal occult blood test (not included as a stand alone test in the ACS guidelines), flexible sigmoidoscopy every 5 years, annual fecal occult blood test plus flexible sigmoidoscopy every 5 years, double-contrast barium enema every 5 to 10 years, and colonoscopy every 10 years.
<table-wrap id="Tab1"><label>Table 1</label><caption><p>
<bold><italic>Recommended options for colorectal cancer screening in asymptomatic, average-risk individuals*</italic></bold>
</p></caption><table frame="hsides" rules="groups"><tbody><tr><td colspan="2">Starting at age 50</td></tr><tr><td/><td>Annual FOBT&#x02020;</td></tr><tr><td/><td>Flexible sigmoidoscopy every 5 years</td></tr><tr><td/><td>Annual FOBT and sigmoidoscopy every 5 years</td></tr><tr><td/><td>Colonoscopy every 10 years</td></tr><tr><td/><td>Double-contrast barium enema every 5&#x02013;10 years</td></tr></tbody></table><table-wrap-foot><p>*Winawer SJ, Fletcher RH, Miller L <italic>et al.</italic> Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology 1997; 112: 594&#x02013;642.</p><p>&#x02020;The American Cancer Society does not recommend fecal occult blood testing (FOBT) by itself.</p></table-wrap-foot></table-wrap></p><sec id="Sec2"><title>Fecal occult blood testing</title><p>Fecal occult blood testing (FOBT) is the safest and least expensive of the currently available screening tests. Three prospective, randomized, controlled trials have demonstrated the effectiveness of FOBT in reducing colorectal cancer mortality by 15% to 33%[<xref ref-type="bibr" rid="CR7">7</xref>&#x02013;<xref ref-type="bibr" rid="CR9">9</xref>]. However, its benefit in reducing colorectal mortality is attributed not only to early cancer detection but also to the incidental discovery and removal of adenomatous polyps at subsequent colonoscopy. Such chance discovery of adenomatous polyps and non-bleeding cancers by colonoscopy has been estimated to account for 16&#x02013;25% of the colorectal cancer deaths prevented by the use of FOBT[<xref ref-type="bibr" rid="CR10">10</xref>]. Limitations of FOBT include its relatively low sensitivity for detecting cancers and its inability to detect the vast majority of adenomas[<xref ref-type="bibr" rid="CR11">11</xref>]. Because colorectal cancers bleed intermittently, 50% or more of patients with colorectal cancer may have a negative test result[<xref ref-type="bibr" rid="CR11">11</xref>,<xref ref-type="bibr" rid="CR12">12</xref>]. Thus, to be effective, FOBT must be administered annually or biennially, which makes patient compliance a problem. Furthermore, the positive predictive value of FOBT is only approximately 10%[<xref ref-type="bibr" rid="CR11">11</xref>,<xref ref-type="bibr" rid="CR12">12</xref>].</p></sec><sec id="Sec3"><title>Flexible sigmoidoscopy</title><p>Data from two case-control studies support the effectiveness of flexible sigmoidoscopy in reducing colorectal cancer mortality[<xref ref-type="bibr" rid="CR13">13</xref>,<xref ref-type="bibr" rid="CR14">14</xref>]. Individuals in these studies who had undergone at least one screening sigmoidoscopy during the previous 10 years had only a 21% to 30% risk of developing fatal colorectal cancer as control subjects. Compared with colonoscopy, flexible sigmoidoscopy is less expensive and has a lower complication rate (approximately one to two perforations per 10 000 examinations)[<xref ref-type="bibr" rid="CR6">6</xref>,<xref ref-type="bibr" rid="CR15">15</xref>]. In addition, it requires a less rigorous bowel preparation and does not require sedation. The major disadvantage of flexible sigmoidoscopy, however, is that it examines only a portion of the colon, thereby enabling detection of only approximately 50% of colonic lesions[<xref ref-type="bibr" rid="CR16">16</xref>,<xref ref-type="bibr" rid="CR17">17</xref>]. If a polyp is detected by sigmoidoscopy, colonoscopy is still needed to evaluate the entire colon.</p></sec><sec id="Sec4"><title>Fecal occult blood testing combined with flexible sigmoidoscopy</title><p>The rationale for combining FOBT with flexible sigmoidoscopy is two-fold: (1) approximately half of the cancers missed by FOBT would be detected at sigmoidoscopy, and (2) FOBT is insensitive for detecting adenomas, many of which would be detected at sigmoidoscopy. Nevertheless, there is little direct evidence to support such a combined approach. Furthermore, a large number of colonic adenomas and carcinomas are not within reach of the sigmoidoscope. Although some of these lesions would be detected when a positive sigmoidoscopy leads to a follow-up colonoscopy or barium enema, many of them would be missed, as up to 50% of proximal colonic cancers are not associated with a distal adenoma[<xref ref-type="bibr" rid="CR18">18</xref>&#x02013;<xref ref-type="bibr" rid="CR22">22</xref>].</p></sec><sec id="Sec5"><title>Colonoscopy</title><p>Colonoscopy is the only colorectal cancer screening test that allows evaluation of the entire colon and provides the opportunity to remove polyps and small polypoid cancers at the same time. Although there are no controlled trials demonstrating that screening colonoscopy reduces colorectal cancer incidence or mortality in those at average risk for the disease, indirect evidence for the effectiveness of colonoscopy comes from one case-control study[<xref ref-type="bibr" rid="CR15">15</xref>] and uncontrolled observational studies[<xref ref-type="bibr" rid="CR23">23</xref>&#x02013;<xref ref-type="bibr" rid="CR25">25</xref>]. The case-control study showed a 40% to 50% reduction in colorectal cancer incidence in individuals who had undergone colonoscopy or polypectomy[<xref ref-type="bibr" rid="CR15">15</xref>]. A limitation of colonoscopy is that it is incomplete in 5&#x02013;15% of patients[<xref ref-type="bibr" rid="CR18">18</xref>,<xref ref-type="bibr" rid="CR19">19</xref>,<xref ref-type="bibr" rid="CR26">26</xref>]. In addition, colonoscopy is associated with the highest risk of complications of all screening tests. Perforation occurs in approximately 1 in 1000 colonoscopies, major bleeding occurs in approximately 3 per 1000, and one to three patients undergoing colonoscopy die of complications from the procedure[<xref ref-type="bibr" rid="CR6">6</xref>,<xref ref-type="bibr" rid="CR19">19</xref>,<xref ref-type="bibr" rid="CR26">26</xref>&#x02013;<xref ref-type="bibr" rid="CR28">28</xref>].</p></sec><sec id="Sec6"><title>Barium enema examination</title><p>Because of its higher sensitivity than single contrast barium enema, double-contrast barium enema is considered the current radiologic alternative to colonoscopy for colorectal cancer detection. Similar to colonoscopy, barium enema examination is a test that allows evaluation of the entire colon in approximately 90&#x02013;95% of patients[<xref ref-type="bibr" rid="CR29">29</xref>&#x02013;<xref ref-type="bibr" rid="CR31">31</xref>]. No data are available on the sensitivity of double-contrast barium enema in a screening population. In patients undergoing diagnostic examinations, the reported sensitivity of this test for the detection of cancer is 85&#x02013;90%[<xref ref-type="bibr" rid="CR32">32</xref>&#x02013;<xref ref-type="bibr" rid="CR34">34</xref>], and the sensitivity for adenomas larger than 1 cm is 75&#x02013;90%[<xref ref-type="bibr" rid="CR35">35</xref>,<xref ref-type="bibr" rid="CR36">36</xref>]. However, recently published data from the National Polyp Study in the United States demonstrated a sensitivity for double-contrast barium enema of only approximately 50% for polyps 1 cm or larger in patients undergoing surveillance after removal of adenomatous polyps[<xref ref-type="bibr" rid="CR37">37</xref>]. Advantages of double-contrast barium enema compared with colonoscopy are that it is safer (approximately one perforation in 25 000 procedures)[<xref ref-type="bibr" rid="CR38">38</xref>], less expensive, and does not require sedation. Its major disadvantages are its lower sensitivity and the inability to remove polyps, thus requiring colonoscopy or sigmoidoscopy after positive examinations.</p></sec><sec id="Sec7"><title>Computed tomography (CT) colonography</title><p>CT colonography (also known as &#x02018;virtual colonoscopy&#x02019;) is a relatively new radiologic procedure that holds promise as a colorectal cancer-screening test, but requires further evaluation. In this study a helically acquired volumetric data set of the abdomen and pelvis is obtained after insufflation of the colon with air or carbon dioxide. The colon can then be viewed with either 2-dimensional or 3-dimensional techniques. The 3-dimensional visualization technique provides a perspective that simulates colonoscopic navigation of the colonic lumen. Prospective studies performed in selected groups of high-risk patients have reported sensitivities with CT colonography of 50% to 91% for polyps 1 cm or larger[<xref ref-type="bibr" rid="CR39">39</xref>&#x02013;<xref ref-type="bibr" rid="CR43">43</xref>]. It is important to note, however, that the results of such studies cannot be generalized to a screening population of average-risk individuals. One potential advantage of CT colonography is the possibility of avoiding rigorous bowel preparation through the use of barium stool tagging and electronic subtraction of stool from the colon prior to diagnostic evaluation of the images[<xref ref-type="bibr" rid="CR44">44</xref>]. Whether CT colonography will become a viable alternative to colonoscopy for colorectal cancer screening remains to be seen.</p></sec><sec id="Sec8"><title>Cost-effectiveness</title><p>Most studies of the cost-effectiveness of FOBT (every 1 to 2 years), flexible sigmoidoscopy (every 5 years), colonoscopy (every 10 years) and double-contrast barium enema examination (every 5 to 10 years) have shown costs per life-year saved ranging from approximately $2000 to $15 000 for FOBT up to $22 000 for colonoscopy[<xref ref-type="bibr" rid="CR45">45</xref>&#x02013;<xref ref-type="bibr" rid="CR48">48</xref>]. These figures compare favorably with estimates of cost per life-year saved for breast cancer, cervical cancer and hypertension screening programs, which range from approximately $9000 to $50 000[<xref ref-type="bibr" rid="CR49">49</xref>&#x02013;<xref ref-type="bibr" rid="CR50">50</xref>].</p></sec><sec id="Sec9"><title>Screening recommendations (Table <xref rid="Tab1" ref-type="table">1</xref>)</title><p>Recommended options for colorectal cancer screening of asymptomatic individuals of average risk include the following (beginning at age 50): annual FOBT (if positive, examine entire colon with colonoscopy or double-contrast barium enema examination), flexible sigmoidoscopy every 5 years (followed by colonoscopy if adenomatous polyp or cancer found), annual FOBT and sigmoidoscopy every 5 years, colonoscopy every 10 years, or double-contrast barium enema examination every 5&#x02013;10 years. It should be noted that the American Cancer Society does not endorse the option of FOBT by itself because of the relatively low mortality reductions that have been associated with its use[<xref ref-type="bibr" rid="CR5">5</xref>].</p></sec></sec><sec id="Sec10"><title>High-risk population</title><p>Individuals at increased risk for colorectal cancer are those with: (1) a personal or family (first degree relative) history of colorectal cancer or adenoma; (2) longstanding ulcerative or Crohn&#x02019;s colitis; or (3) a genetic predisposition to a hereditary polyposis or nonpolyposis syndrome. Individuals with a single first-degree relative with colorectal cancer have a risk of developing colorectal cancer approximately 1.7 times that of the general population[<xref ref-type="bibr" rid="CR51">51</xref>]. In addition, cancers tend to occur at an earlier age in this population. First-degree relatives of patients with adenomas have a similar increased risk of colorectal cancer[<xref ref-type="bibr" rid="CR52">52</xref>,<xref ref-type="bibr" rid="CR53">53</xref>]. Patients with long-standing ulcerative colitis are at increased risk for colorectal cancer, particularly those with pancolitis and early age of onset of their disease[<xref ref-type="bibr" rid="CR54">54</xref>]. Colorectal cancer in this group of patients is thought to develop in areas of mucosal dysplasia. Patients with longstanding Crohn&#x02019;s colitis are also at increased risk for colorectal cancer, but the risk is lower than that associated with ulcerative colitis[<xref ref-type="bibr" rid="CR55">55</xref>]. Familial adenomatous polyposis coli (FAP) is a disease that results from inherited or acquired defects in the APC gene located on the fifth chromosome. Patients with this disease develop numerous polyps throughout the colon, which results in a 100% risk of colorectal cancer if the colon is not removed. Hereditary nonpolyposis colorectal cancer (HNPCC) is an autosomal dominant disorder that results in a familial predisposition to multiple cancers. The colon cancers typically occur at a young age, are often located in the right colon, and may be associated with extracolonic neoplasms[<xref ref-type="bibr" rid="CR56">56</xref>].</p><sec id="Sec11"><title>Screening recommendations (Table <xref rid="Tab2" ref-type="table">2</xref>)</title><p>For individuals with first-degree relatives with colorectal cancer or an adenomatous polyp, the screening recommendations are the same as for the average risk population, except that screening should begin at age 40. (Patients with a personal history of colorectal cancer or adenomatous polyp are not included in this discussion, as they fall under the category of surveillance rather than screening.) The recommendation for patients with FAP is to receive genetic counseling (and possibly genetic testing to determine if the patient is a gene carrier) and to undergo flexible sigmoidoscopy annually beginning at puberty. The recommendation for patients with HNPCC is to receive genetic counseling (and possibly genetic testing) and to undergo colonoscopy every 1&#x02013;2 years beginning at age 20&#x02013;30, with annual colonoscopies beginning at age 40. The recommendation for patients with longstanding ulcerative colitis is to undergo colonoscopy with biopsies looking for dysplasia every 1&#x02013;2 years beginning 8 years after diagnosis for pancolitis and beginning 15 years after diagnosis for left-sided disease. However, there is no direct evidence that this practice reduces colorectal cancer mortality in these patients and none that it is more effective than colectomy based on extent and duration of disease[<xref ref-type="bibr" rid="CR6">6</xref>]. Surveillance for colorectal cancer is not currently recommended for patients with Crohn&#x02019;s colitis[<xref ref-type="bibr" rid="CR57">57</xref>].
<table-wrap id="Tab2"><label>Table 2</label><caption><p>
<bold><italic>Recommendations for colorectal cancer screening in individuals at increased risk*</italic></bold>
</p></caption><table frame="hsides" rules="groups"><tbody><tr><td colspan="2">First-degree relative with colorectal cancer or adenomatous polyp(s): same as for average risk individual, but begin at age 40</td></tr><tr><td colspan="2">Family history of FAP</td></tr><tr><td/><td>Genetic counseling (consider genetic testing)</td></tr><tr><td/><td>Annual flexible sigmoidoscopy beginning at puberty if gene carrier or indeterminate</td></tr><tr><td colspan="2">Family history of HNPCC</td></tr><tr><td/><td>Genetic counseling (consider genetic testing)</td></tr><tr><td/><td>Colonoscopy every 1&#x02013;2 years beginning at age 20&#x02013;30, annually beginning at age 40</td></tr><tr><td colspan="2">History of inflammatory bowel disease</td></tr><tr><td/><td>Consider colonoscopy surveillance for dysplasia every 1&#x02013;2 years beginning after 8 years of disease for pancolitis and after 15 years of disease for left-sided colitis</td></tr></tbody></table><table-wrap-foot><p>*Winawer SJ, Fletcher RH, Miller L <italic>et al.</italic> Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology 1997; 112: 594&#x02013;642.</p><p>FAP, familial adenomatous polyposis; HNPCC, hereditary nonpolyposis colorectal cancer.</p></table-wrap-foot></table-wrap></p></sec></sec></body><back><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>[1]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Greenlee</surname><given-names>RT</given-names></name><name><surname>Murray</surname><given-names>P</given-names></name><name><surname>Bolden</surname><given-names>S</given-names></name><name><surname>Wingo</surname><given-names>PA</given-names></name></person-group><article-title>Cancer statistics: 2000</article-title><source>CA Cancer J Clin</source><year>2000</year><volume>50</volume><fpage>7</fpage><lpage>33</lpage><pub-id pub-id-type="doi">10.3322/canjclin.50.1.7</pub-id><pub-id pub-id-type="pmid">10735013</pub-id></element-citation></ref><ref id="CR2"><label>[2]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bond</surname><given-names>JH</given-names></name></person-group><article-title>Screening guidelines for colorectal cancer</article-title><source>Am J Med</source><year>1999</year><volume>106</volume><issue>1A</issue><fpage>7S</fpage><lpage>10S</lpage><pub-id pub-id-type="doi">10.1016/S0002-9343(98)00339-8</pub-id><pub-id pub-id-type="pmid">10089107</pub-id></element-citation></ref><ref id="CR3"><label>[3]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vernon</surname><given-names>SW</given-names></name></person-group><article-title>Participation in colorectal cancer screening: a review</article-title><source>J Natl Cancer Inst</source><year>1997</year><volume>89</volume><fpage>1406</fpage><lpage>23</lpage><pub-id pub-id-type="doi">10.1093/jnci/89.19.1406</pub-id><pub-id pub-id-type="pmid">9326910</pub-id></element-citation></ref><ref id="CR4"><label>[4]</label><element-citation publication-type="journal"><person-group person-group-type="author"><collab>Centers for Disease Control</collab></person-group><article-title>Screening for colorectal cancer &#x02014; United States, 1997</article-title><source>MMWR</source><year>1999</year><volume>48</volume><fpage>116</fpage><lpage>121</lpage><pub-id pub-id-type="pmid">10073920</pub-id></element-citation></ref><ref id="CR5"><label>[5]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Byers</surname><given-names>T</given-names></name><name><surname>Levin</surname><given-names>B</given-names></name><name><surname>Rothenberger</surname><given-names>D</given-names></name></person-group><article-title>American Cancer Society guidelines for screening and surveillance for early detection of colorectal polyps and cancer: update 1997. American Cancer Society Detection and Treatment Advisory Group on Colorectal Cancer</article-title><source>CA Cancer J Clin</source><year>1997</year><volume>47</volume><fpage>154</fpage><lpage>60</lpage><pub-id pub-id-type="doi">10.3322/canjclin.47.3.154</pub-id><pub-id pub-id-type="pmid">9152173</pub-id></element-citation></ref><ref id="CR6"><label>[6]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Winawer</surname><given-names>SJ</given-names></name><name><surname>Fletcher</surname><given-names>RH</given-names></name><name><surname>Miller</surname><given-names>L</given-names></name><etal/></person-group><article-title>Colorectal cancer screening: clinical guidelines and rationale</article-title><source>Gastroenterology</source><year>1997</year><volume>112</volume><fpage>594</fpage><lpage>642</lpage><pub-id pub-id-type="doi">10.1053/gast.1997.v112.agast970594</pub-id><pub-id pub-id-type="pmid">9024315</pub-id></element-citation></ref><ref id="CR7"><label>[7]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mandel</surname><given-names>JS</given-names></name><name><surname>Bond</surname><given-names>JH</given-names></name><name><surname>Church</surname><given-names>TR</given-names></name><etal/></person-group><article-title>Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study</article-title><source>N Engl J Med</source><year>1993</year><volume>328</volume><fpage>1365</fpage><lpage>71</lpage><pub-id pub-id-type="doi">10.1056/NEJM199305133281901</pub-id><pub-id pub-id-type="pmid">8474513</pub-id></element-citation></ref><ref id="CR8"><label>[8]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kronborg</surname><given-names>O</given-names></name><name><surname>Fenger</surname><given-names>C</given-names></name><name><surname>Olsen</surname><given-names>J</given-names></name><etal/></person-group><article-title>Randomized study of screening for colorectal cancer with faecal-occult-blood test</article-title><source>Lancet</source><year>1996</year><volume>348</volume><fpage>1467</fpage><lpage>71</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(96)03430-7</pub-id><pub-id pub-id-type="pmid">8942774</pub-id></element-citation></ref><ref id="CR9"><label>[9]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hardcastle</surname><given-names>JD</given-names></name><name><surname>Chamberlain</surname><given-names>JO</given-names></name><name><surname>Robinson</surname><given-names>MHE</given-names></name><etal/></person-group><article-title>Randomized controlled trial of faecal-occult-blood screening for colorectal cancer</article-title><source>Lancet</source><year>1996</year><volume>348</volume><fpage>1472</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(96)03386-7</pub-id><pub-id pub-id-type="pmid">8942775</pub-id></element-citation></ref><ref id="CR10"><label>[10]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ederer</surname><given-names>F</given-names></name><name><surname>Church</surname><given-names>TR</given-names></name><name><surname>Mandel</surname><given-names>JS</given-names></name></person-group><article-title>Fecal occult blood screening in the Minnesota study: role of chance detection of lesions</article-title><source>J Natl Cancer Inst</source><year>1997</year><volume>89</volume><fpage>1423</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1093/jnci/89.19.1423</pub-id><pub-id pub-id-type="pmid">9326911</pub-id></element-citation></ref><ref id="CR11"><label>[11]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahlquist</surname><given-names>DA</given-names></name><name><surname>Wieand</surname><given-names>HS</given-names></name><name><surname>Moertel</surname><given-names>CG</given-names></name><etal/></person-group><article-title>Accuracy of fecal occult blood screening for colorectal neoplasia: a prospective study using Hemoccult and HemoQuant tests</article-title><source>JAMA</source><year>1993</year><volume>269</volume><fpage>1262</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1001/jama.1993.03500100060028</pub-id><pub-id pub-id-type="pmid">8437303</pub-id></element-citation></ref><ref id="CR12"><label>[12]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Allison</surname><given-names>JE</given-names></name><name><surname>Tekawa</surname><given-names>IS</given-names></name><name><surname>Ransom</surname><given-names>LJ</given-names></name><etal/></person-group><article-title>A comparison of fecal occult-blood tests for colorectal-cancer screening</article-title><source>N Engl J Med</source><year>1996</year><volume>334</volume><fpage>155</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1056/NEJM199601183340304</pub-id><pub-id pub-id-type="pmid">8531970</pub-id></element-citation></ref><ref id="CR13"><label>[13]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Selby</surname><given-names>JV</given-names></name><name><surname>Friedman</surname><given-names>GD</given-names></name><name><surname>Quesenberry</surname><given-names>CPJ</given-names></name><etal/></person-group><article-title>A case-control study of screening sigmoidoscopy and mortality from colorectal cancer</article-title><source>N Engl J Med</source><year>1992</year><volume>326</volume><fpage>653</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1056/NEJM199203053261001</pub-id><pub-id pub-id-type="pmid">1736103</pub-id></element-citation></ref><ref id="CR14"><label>[14]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Newcomb</surname><given-names>PA</given-names></name><name><surname>Norfleet</surname><given-names>RG</given-names></name><name><surname>Storer</surname><given-names>BE</given-names></name><etal/></person-group><article-title>Screening sigmoidoscopy and colorectal cancer mortality</article-title><source>J Natl Cancer Inst</source><year>1992</year><volume>84</volume><fpage>1572</fpage><lpage>5</lpage><pub-id pub-id-type="doi">10.1093/jnci/84.20.1572</pub-id><pub-id pub-id-type="pmid">1404450</pub-id></element-citation></ref><ref id="CR15"><label>[15]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Muller</surname><given-names>AD</given-names></name><name><surname>Sonnenberg</surname><given-names>A</given-names></name></person-group><article-title>Prevention of colorectal cancer by flexible endoscopy and polypectomy: a case-control study of 32 702 veterans</article-title><source>Ann Intern Med</source><year>1995</year><volume>123</volume><fpage>904</fpage><lpage>10</lpage><pub-id pub-id-type="doi">10.7326/0003-4819-123-12-199512150-00002</pub-id><pub-id pub-id-type="pmid">7486484</pub-id></element-citation></ref><ref id="CR16"><label>[16]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Selby</surname><given-names>JV</given-names></name><name><surname>Friedman</surname><given-names>GD</given-names></name></person-group><article-title>US preventative task force. Sigmoidoscopy in the periodic health examination of asymptomatic adults</article-title><source>JAMA</source><year>1989</year><volume>261</volume><fpage>594</fpage><lpage>601</lpage><pub-id pub-id-type="doi">10.1001/jama.1989.03420040132033</pub-id><pub-id pub-id-type="pmid">2642564</pub-id></element-citation></ref><ref id="CR17"><label>[17]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Selby</surname><given-names>JV</given-names></name><name><surname>Friedman</surname><given-names>GD</given-names></name><name><surname>Collen</surname><given-names>MF</given-names></name></person-group><article-title>Sigmoidoscopy and mortality from colorectal cancer: the Kaiser Permanente Multiplastic Evaluation study</article-title><source>J Clin Epidemiol</source><year>1988</year><volume>41</volume><fpage>427</fpage><lpage>34</lpage><pub-id pub-id-type="doi">10.1016/0895-4356(88)90043-1</pub-id><pub-id pub-id-type="pmid">3367172</pub-id></element-citation></ref><ref id="CR18"><label>[18]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lieberman</surname><given-names>DA</given-names></name><name><surname>Smith</surname><given-names>FW</given-names></name></person-group><article-title>Screening for colon malignancy with colonoscopy</article-title><source>Am J Gastroenterol</source><year>1991</year><volume>86</volume><fpage>1775</fpage><lpage>80</lpage></element-citation></ref><ref id="CR19"><label>[19]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rex</surname><given-names>DK</given-names></name><name><surname>Lehman</surname><given-names>GA</given-names></name><name><surname>Hawes</surname><given-names>RH</given-names></name><etal/></person-group><article-title>Screening colonoscopy in symptomatic average-risk persons with negative fecal occult blood tests</article-title><source>Gastroenterology</source><year>1991</year><volume>100</volume><fpage>64</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">1796931</pub-id></element-citation></ref><ref id="CR20"><label>[20]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kadakia</surname><given-names>SC</given-names></name><name><surname>Wrobleski</surname><given-names>CS</given-names></name><name><surname>Kadakia</surname><given-names>AS</given-names></name><etal/></person-group><article-title>Prevalence or proximal colonic polyps in average-risk asymptomatic patients with negative fecal occult blood test and flexible sigmoidoscopy</article-title><source>Gastrointest Endosc</source><year>1996</year><volume>44</volume><fpage>112</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1016/S0016-5107(96)70126-8</pub-id><pub-id pub-id-type="pmid">8858314</pub-id></element-citation></ref><ref id="CR21"><label>[21]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lemmel</surname><given-names>TG</given-names></name><name><surname>Haseman</surname><given-names>JH</given-names></name><name><surname>Rex</surname><given-names>DK</given-names></name><etal/></person-group><article-title>Neoplasia distal to the splenic flexure in patients with proximal colon cancer</article-title><source>Gastrointest Endosc</source><year>1996</year><volume>44</volume><fpage>109</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.1016/S0016-5107(96)70125-6</pub-id><pub-id pub-id-type="pmid">8858313</pub-id></element-citation></ref><ref id="CR22"><label>[22]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Imperiale</surname><given-names>TF</given-names></name><name><surname>Wagner</surname><given-names>DR</given-names></name><name><surname>Ching</surname><given-names>YL</given-names></name><name><surname>Larkin</surname><given-names>GN</given-names></name><name><surname>Rogge</surname><given-names>JD</given-names></name><name><surname>Ransohoff</surname><given-names>DF</given-names></name></person-group><article-title>Risk of advanced proximal neoplasms in asymptomatic adults according to the distal colorectal findings</article-title><source>N Engl J Med</source><year>2000</year><volume>343</volume><fpage>169</fpage><lpage>74</lpage><pub-id pub-id-type="doi">10.1056/NEJM200007203430302</pub-id><pub-id pub-id-type="pmid">10900275</pub-id></element-citation></ref><ref id="CR23"><label>[23]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Winawer</surname><given-names>SJ</given-names></name><name><surname>Zauber</surname><given-names>AG</given-names></name><name><surname>Ho</surname><given-names>MN</given-names></name><etal/></person-group><article-title>Prevention of colorectal cancer by colonoscopic polypectomy</article-title><source>N Engl J Med</source><year>1977</year><volume>329</volume><fpage>1977</fpage><lpage>81</lpage><pub-id pub-id-type="doi">10.1056/NEJM199312303292701</pub-id><pub-id pub-id-type="pmid">8247072</pub-id></element-citation></ref><ref id="CR24"><label>[24]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>J&#x000f8;gensen</surname><given-names>OD</given-names></name><name><surname>Kronborg</surname><given-names>O</given-names></name><name><surname>Fenger</surname><given-names>C</given-names></name></person-group><article-title>The Funen adenoma follow-up study: Incidence and death from colorectal carcinoma in an adenoma surveillance program</article-title><source>Scand J Gastroenterol</source><year>1993</year><volume>28</volume><fpage>869</fpage><lpage>74</lpage><pub-id pub-id-type="doi">10.3109/00365529309103127</pub-id><pub-id pub-id-type="pmid">8266015</pub-id></element-citation></ref><ref id="CR25"><label>[25]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rex</surname><given-names>DK</given-names></name></person-group><article-title>Colonoscopy: a review of its yield for cancer and adenomas by indication</article-title><source>Am J Gastroenterol</source><year>1995</year><volume>3</volume><fpage>353</fpage><lpage>65</lpage><pub-id pub-id-type="pmid">7872270</pub-id></element-citation></ref><ref id="CR26"><label>[26]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Godreau</surname><given-names>CJ</given-names></name></person-group><article-title>Office-based colonoscopy in a family practice</article-title><source>Fam Pract Res J</source><year>1992</year><volume>12</volume><fpage>313</fpage><lpage>20</lpage><pub-id pub-id-type="pmid">1414436</pub-id></element-citation></ref><ref id="CR27"><label>[27]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jentschura</surname><given-names>D</given-names></name><name><surname>Raute</surname><given-names>M</given-names></name><name><surname>Winter</surname><given-names>J</given-names></name><etal/></person-group><article-title>Complications in endoscopy of the lower gastrointestinal tract: therapy and prognosis</article-title><source>Surg Endosc</source><year>1994</year><volume>8</volume><fpage>672</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1007/BF00678564</pub-id><pub-id pub-id-type="pmid">8059305</pub-id></element-citation></ref><ref id="CR28"><label>[28]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Waye</surname><given-names>JD</given-names></name><name><surname>Lewis</surname><given-names>BS</given-names></name><name><surname>Yessayan</surname><given-names>S</given-names></name></person-group><article-title>Colonoscopy: a prospective report of complications</article-title><source>J Clin Gastroenterol</source><year>1992</year><volume>15</volume><fpage>347</fpage><lpage>51</lpage><pub-id pub-id-type="doi">10.1097/00004836-199212000-00018</pub-id><pub-id pub-id-type="pmid">1294644</pub-id></element-citation></ref><ref id="CR29"><label>[29]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bloomfield</surname><given-names>JA</given-names></name></person-group><article-title>Reliability of barium enema in detecting colonic neoplasia</article-title><source>Med J Austr</source><year>1981</year><volume>1</volume><fpage>631</fpage><lpage>3</lpage></element-citation></ref><ref id="CR30"><label>[30]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jaramillo</surname><given-names>E</given-names></name><name><surname>Slezak</surname><given-names>P</given-names></name></person-group><article-title>Comparison between double-contrast barium enema and colonoscopy to investigate lower gastrointestinal bleeding</article-title><source>Gastrointest Radiol</source><year>1992</year><volume>17</volume><fpage>81</fpage><lpage>3</lpage><pub-id pub-id-type="doi">10.1007/BF01888514</pub-id><pub-id pub-id-type="pmid">1544563</pub-id></element-citation></ref><ref id="CR31"><label>[31]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brewster</surname><given-names>NT</given-names></name><name><surname>Grieve</surname><given-names>DC</given-names></name><name><surname>Saunders</surname><given-names>JH</given-names></name></person-group><article-title>Double-contrast barium enema and flexible sigmoidoscopy for routine colonic investigation</article-title><source>Br J Surg</source><year>1994</year><volume>8</volume><fpage>445</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1002/bjs.1800810341</pub-id><pub-id pub-id-type="pmid">8173926</pub-id></element-citation></ref><ref id="CR32"><label>[32]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rex</surname><given-names>DK</given-names></name><name><surname>Rahmani</surname><given-names>EY</given-names></name><name><surname>Haseman</surname><given-names>JH</given-names></name><etal/></person-group><article-title>Relative sensitivity of colonoscopy and barium enema for detection of colorectal cancer in clinical practice</article-title><source>Gastroenterology</source><year>1997</year><volume>112</volume><fpage>17</fpage><lpage>23</lpage><pub-id pub-id-type="doi">10.1016/S0016-5085(97)70213-0</pub-id><pub-id pub-id-type="pmid">8978337</pub-id></element-citation></ref><ref id="CR33"><label>[33]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fork</surname><given-names>FT</given-names></name><name><surname>Lindstrom</surname><given-names>C</given-names></name><name><surname>Ekelund</surname><given-names>G</given-names></name></person-group><article-title>Double contrast examination in carcinoma of the colon and rectum: a prospective clinical series</article-title><source>Acta Radiol</source><year>1983</year><volume>24</volume><fpage>177</fpage><lpage>88</lpage></element-citation></ref><ref id="CR34"><label>[34]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname><given-names>DC</given-names></name><name><surname>Carlson</surname><given-names>HC</given-names></name><name><surname>Taylor</surname><given-names>WE</given-names></name><etal/></person-group><article-title>Barium enema of carcinoma of the colon: sensitivity of double- and single-contrast studies</article-title><source>Am J Radiol</source><year>1983</year><volume>140</volume><fpage>1143</fpage><lpage>9</lpage></element-citation></ref><ref id="CR35"><label>[35]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fork</surname><given-names>FT</given-names></name></person-group><article-title>Double contrast enema and colonoscopy in polyp detection</article-title><source>Gut</source><year>1981</year><volume>22</volume><fpage>971</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1136/gut.22.11.971</pub-id><pub-id pub-id-type="pmid">7308852</pub-id></element-citation></ref><ref id="CR36"><label>[36]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Steine</surname><given-names>S</given-names></name><name><surname>Stordahl</surname><given-names>A</given-names></name><name><surname>Lunde</surname><given-names>OC</given-names></name><etal/></person-group><article-title>Double-contrast barium enema versus colonoscopy in the diagnosis of neoplastic disorders: aspects of decision-making in general practice</article-title><source>Fam Pract</source><year>1993</year><volume>10</volume><fpage>288</fpage><lpage>91</lpage><pub-id pub-id-type="doi">10.1093/fampra/10.3.288</pub-id><pub-id pub-id-type="pmid">8282153</pub-id></element-citation></ref><ref id="CR37"><label>[37]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Winawer</surname><given-names>SJ</given-names></name><name><surname>Stewart</surname><given-names>ET</given-names></name><name><surname>Zauber</surname><given-names>AG</given-names></name><etal/></person-group><article-title>A comparison of colonoscopy and double-contrast barium enema for surveillance after polypectomy</article-title><source>N Engl J Med</source><year>2000</year><volume>342</volume><fpage>1766</fpage><lpage>72</lpage><pub-id pub-id-type="doi">10.1056/NEJM200006153422401</pub-id><pub-id pub-id-type="pmid">10852998</pub-id></element-citation></ref><ref id="CR38"><label>[38]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blakeborough</surname><given-names>A</given-names></name><name><surname>Sheridan</surname><given-names>MB</given-names></name><name><surname>Chapman</surname><given-names>AH</given-names></name></person-group><article-title>Complications of barium enema examinations: a survey of UK consultant radiologists 1992&#x02013;1994</article-title><source>Clin Radiol</source><year>1992</year><volume>52</volume><fpage>142</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1016/S0009-9260(97)80108-0</pub-id><pub-id pub-id-type="pmid">9043049</pub-id></element-citation></ref><ref id="CR39"><label>[39]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hara</surname><given-names>AJ</given-names></name><name><surname>Johnson</surname><given-names>CD</given-names></name><name><surname>Reed</surname><given-names>JE</given-names></name><etal/></person-group><article-title>Detection of colorectal polyps with CT colography: initial assessment of sensitivity and specificity</article-title><source>Radiology</source><year>1997</year><volume>205</volume><fpage>59</fpage><lpage>65</lpage><pub-id pub-id-type="doi">10.1148/radiology.205.1.9314963</pub-id><pub-id pub-id-type="pmid">9314963</pub-id></element-citation></ref><ref id="CR40"><label>[40]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fenlon</surname><given-names>HM</given-names></name><name><surname>Nunes</surname><given-names>DP</given-names></name><name><surname>Schroy</surname><given-names>PC</given-names></name><etal/></person-group><article-title>A comparison of virtual and conventional colonoscopy for the detection of colorectal polyps</article-title><source>N Engl J Med</source><year>1999</year><volume>341</volume><fpage>1496</fpage><lpage>503</lpage><pub-id pub-id-type="doi">10.1056/NEJM199911113412003</pub-id><pub-id pub-id-type="pmid">10559450</pub-id></element-citation></ref><ref id="CR41"><label>[41]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kay</surname><given-names>CL</given-names></name><name><surname>Kulling</surname><given-names>D</given-names></name><name><surname>Hawes</surname><given-names>HR</given-names></name><name><surname>Young</surname><given-names>JWR</given-names></name><name><surname>Cotton</surname><given-names>PB</given-names></name></person-group><article-title>Virtual endoscopy &#x02014; comparison with colonoscopy in the detection of space-occupying lesions of the colon</article-title><source>Endoscopy</source><year>2000</year><volume>32</volume><fpage>226</fpage><lpage>32</lpage><pub-id pub-id-type="doi">10.1055/s-2000-100</pub-id><pub-id pub-id-type="pmid">10718388</pub-id></element-citation></ref><ref id="CR42"><label>[42]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rex</surname><given-names>DK</given-names></name><name><surname>Vining</surname><given-names>D</given-names></name><name><surname>Kopecky</surname><given-names>KK</given-names></name></person-group><article-title>An initial experience with screening for colon polyps using spiral CT with and without CT colography (virtual colonoscopy)</article-title><source>Gastrointest Endosc</source><year>1999</year><volume>50</volume><fpage>309</fpage><lpage>13</lpage><pub-id pub-id-type="doi">10.1053/ge.1999.v50.97776</pub-id><pub-id pub-id-type="pmid">10462648</pub-id></element-citation></ref><ref id="CR43"><label>[43]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yee</surname><given-names>J</given-names></name><name><surname>Akerkar</surname><given-names>GA</given-names></name><name><surname>Hung</surname><given-names>RK</given-names></name><etal/></person-group><article-title>Colorectal neoplasia: performance characteristics of CT colonography for detection in 300 patients</article-title><source>Radiology</source><year>2001</year><volume>219</volume><fpage>685</fpage><lpage>92</lpage><pub-id pub-id-type="doi">10.1148/radiology.219.3.r01jn40685</pub-id><pub-id pub-id-type="pmid">11376255</pub-id></element-citation></ref><ref id="CR44"><label>[44]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Callstrom</surname><given-names>MR</given-names></name><name><surname>Johnson</surname><given-names>CD</given-names></name><name><surname>Fletcher</surname><given-names>JG</given-names></name><etal/></person-group><article-title>CT colonography without cathartic preparation: feasibility study</article-title><source>Radiology</source><year>2001</year><volume>219</volume><fpage>693</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1148/radiology.219.3.r01jn22693</pub-id><pub-id pub-id-type="pmid">11376256</pub-id></element-citation></ref><ref id="CR45"><label>[45]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eddy</surname><given-names>DM</given-names></name></person-group><article-title>Screening for colorectal cancer</article-title><source>Ann Intern Med</source><year>1990</year><volume>113</volume><fpage>373</fpage><lpage>84</lpage><pub-id pub-id-type="doi">10.7326/0003-4819-113-5-373</pub-id><pub-id pub-id-type="pmid">2200321</pub-id></element-citation></ref><ref id="CR46"><label>[46]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Glick</surname><given-names>S</given-names></name><name><surname>Wagner</surname><given-names>JL</given-names></name><name><surname>Johnson</surname><given-names>CD</given-names></name></person-group><article-title>Cost-effectiveness of double-contrast barium enema in screening for colorectal cancer</article-title><source>Am J Radiol</source><year>1998</year><volume>170</volume><fpage>629</fpage><lpage>36</lpage></element-citation></ref><ref id="CR47"><label>[47]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gyrd-Hansen</surname><given-names>D</given-names></name></person-group><article-title>Fecal occult blood tests: a cost-effectiveness analysis</article-title><source>Int J Technol Asses Health Care</source><year>1998</year><volume>14</volume><fpage>290</fpage><lpage>301</lpage><pub-id pub-id-type="doi">10.1017/S0266462300012265</pub-id></element-citation></ref><ref id="CR48"><label>[48]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Whynes</surname><given-names>DK</given-names></name><name><surname>Nielson</surname><given-names>AR</given-names></name><name><surname>Walker</surname><given-names>AR</given-names></name><etal/></person-group><article-title>Fecal occult blood screening for colorectal cancer: is it cost-effective?</article-title><source>Health Econ</source><year>1998</year><volume>7</volume><fpage>21</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1002/(SICI)1099-1050(199802)7:1&#x0003c;21::AID-HEC306&#x0003e;3.0.CO;2-9</pub-id><pub-id pub-id-type="pmid">9541081</pub-id></element-citation></ref><ref id="CR49"><label>[49]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garber</surname><given-names>AM</given-names></name><name><surname>Phelps</surname><given-names>CE</given-names></name></person-group><article-title>Economic foundation of cost-effectiveness analysis</article-title><source>J Health Econ</source><year>1997</year><volume>16</volume><fpage>1</fpage><lpage>31</lpage><pub-id pub-id-type="doi">10.1016/S0167-6296(96)00506-1</pub-id><pub-id pub-id-type="pmid">10167341</pub-id></element-citation></ref><ref id="CR50"><label>[50]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname><given-names>ML</given-names></name><name><surname>Fintor</surname><given-names>L</given-names></name></person-group><article-title>Cost-effectiveness of breast cancer screening: preliminary results of a systematic review of the literature</article-title><source>Breast Cancer Res Treat</source><year>1993</year><volume>25</volume><fpage>113</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1007/BF00662136</pub-id><pub-id pub-id-type="pmid">8347843</pub-id></element-citation></ref><ref id="CR51"><label>[51]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fuchs</surname><given-names>CS</given-names></name><name><surname>Giovannucci</surname><given-names>EL</given-names></name><name><surname>Colditz</surname><given-names>G</given-names></name></person-group><article-title>A prospective study of family history and the risk of colorectal cancer</article-title><source>N Engl J Med</source><year>1994</year><volume>331</volume><fpage>1669</fpage><lpage>74</lpage><pub-id pub-id-type="doi">10.1056/NEJM199412223312501</pub-id><pub-id pub-id-type="pmid">7969357</pub-id></element-citation></ref><ref id="CR52"><label>[52]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahsan</surname><given-names>H</given-names></name><name><surname>Neugut</surname><given-names>AI</given-names></name><name><surname>Garbowski</surname><given-names>CG</given-names></name><etal/></person-group><article-title>Family history of colorectal adenomatous polyps and increased risk for colorectal cancer</article-title><source>Ann Intern Med</source><year>1998</year><volume>128</volume><fpage>900</fpage><lpage>5</lpage><pub-id pub-id-type="doi">10.7326/0003-4819-128-11-199806010-00006</pub-id><pub-id pub-id-type="pmid">9634428</pub-id></element-citation></ref><ref id="CR53"><label>[53]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Winawer</surname><given-names>SJ</given-names></name><name><surname>Zauber</surname><given-names>AG</given-names></name><name><surname>Gerdes</surname><given-names>H</given-names></name><etal/></person-group><article-title>Risk of colorectal cancer in the families of patients with adenomatous polyps. National Polyp Study Workgroup</article-title><source>N Engl J Med</source><year>1996</year><volume>334</volume><fpage>82</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1056/NEJM199601113340204</pub-id><pub-id pub-id-type="pmid">8531963</pub-id></element-citation></ref><ref id="CR54"><label>[54]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ekbom</surname><given-names>A</given-names></name><name><surname>Helmick</surname><given-names>C</given-names></name><name><surname>Zack</surname><given-names>M</given-names></name><etal/></person-group><article-title>Ulcerative colitis and colorectal cancer. A population-based study</article-title><source>N Engl J Med</source><year>1990</year><volume>323</volume><fpage>1228</fpage><lpage>33</lpage><pub-id pub-id-type="doi">10.1056/NEJM199011013231802</pub-id><pub-id pub-id-type="pmid">2215606</pub-id></element-citation></ref><ref id="CR55"><label>[55]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ekbom</surname><given-names>A</given-names></name><name><surname>Helmick</surname><given-names>C</given-names></name><name><surname>Zack</surname><given-names>M</given-names></name><etal/></person-group><article-title>Increased risk of large-bowel cancer in Crohn&#x02019;s disease with colonic involvement</article-title><source>Lancet</source><year>1990</year><volume>336</volume><fpage>357</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1016/0140-6736(90)91889-I</pub-id><pub-id pub-id-type="pmid">1975343</pub-id></element-citation></ref><ref id="CR56"><label>[56]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vasen</surname><given-names>HF</given-names></name><name><surname>Wijnen</surname><given-names>JT</given-names></name><name><surname>Menko</surname><given-names>FH</given-names></name><etal/></person-group><article-title>Cancer risk in families with hereditary non-polyposis colorectal cancer diagnosed by mutation analysis</article-title><source>Gastroenterology</source><year>1996</year><volume>110</volume><fpage>1020</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1053/gast.1996.v110.pm8612988</pub-id><pub-id pub-id-type="pmid">8612988</pub-id></element-citation></ref><ref id="CR57"><label>[57]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Helm</surname><given-names>JF</given-names></name><name><surname>Sandler</surname><given-names>RS</given-names></name></person-group><article-title>Colorectal cancer screening</article-title><source>Med Clin N Am</source><year>1999</year><volume>83</volume><fpage>1403</fpage><lpage>22</lpage><pub-id pub-id-type="doi">10.1016/S0025-7125(05)70172-3</pub-id><pub-id pub-id-type="pmid">10584600</pub-id></element-citation></ref></ref-list></back></article>